Description
NSE announces listing of Sheel Biotech Limited equity shares on EMERGE SME Platform effective October 08, 2025, with trade-for-trade surveillance segment.
Summary
National Stock Exchange announces the listing of equity shares of Sheel Biotech Limited on the EMERGE SME Platform effective October 08, 2025. The security will initially trade in Series ‘ST’ (Trade for Trade Surveillance Segment with Settlement Type ‘W’) and subsequently shift to Series ‘SM’ (Normal Rolling Segment). The company has 20,352,550 equity shares of Rs. 10/- face value with IPO price of Rs. 63/- per share.
Key Points
- Symbol: SHEEL
- ISIN: INE0YJV01017
- Face Value: Rs. 10/-
- IPO Price: Rs. 63/- per share
- Total Shares: 20,352,550 equity shares
- Market Lot: 2,000 equity shares
- Trading Series: ST (Trade for Trade Surveillance Segment - TFTS, Settlement Type ‘W’)
- Market Type: Continuous Market
- Market Maker Maximum Spread: Within 10%
- Pre-open Session: Applicable for IPO and Other category scrips
Regulatory Changes
No regulatory changes. This circular follows existing SEBI regulations:
- SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012 for pre-open session
- Exchange Circular No. NSE/CMTR/37202 dated March 14, 2018 for continuous market trading
Compliance Requirements
- Members must identify the security by its designated code (SHEEL)
- Trading must be conducted in specified lot sizes of 2,000 equity shares
- Market Maker minimum quantity: 2,000 equity shares
- The security will be part of pre-open session for IPO category
Important Dates
- Effective Date: October 08, 2025
- Financial Year: April 2025 – March 2026
Impact Assessment
Minimal market impact. This is a standard SME IPO listing on the EMERGE platform. The trade-for-trade surveillance segment (Series ST) indicates enhanced monitoring, which is typical for new SME listings. The security will later transition to normal rolling segment (Series SM) as per standard procedure.
Company Details
Registered Office: Sheel Biotech Limited 8 Balaji Estates, 2nd Floor, Block-C, Guru Ravidas Marg, Kalkaji South Delhi, New Delhi - 110019 Tel: +91-8851189801 Email: compliance@sheelbiotech.com Website: www.sheelbiotech.com
Company Secretary and Compliance Officer: Mr. Anupam Pandey Tel: +91-8851189801 Email: compliance@sheelbiotech.com
Registrar & Transfer Agent: Skyline Financial Services Private Limited D-153 A, 1st Floor, Okhla Industrial Area, Phase – I New Delhi-110020 Tel: +91-11-40450193-97 Email: compliances@skylinerta.com Contact Person: Mr. Anuj Rana
Market Maker: Mansi Share and Stock Broking Private Limited B-201, Avirahi Building, Behind Adidas Showroom, S.V. Road Borivali (West) Mumbai – 400092 Tel: 02240503870 Email: compliance@mansishares.in Contact Person: Mr. Deep Paresh Shah
Impact Justification
Routine SME IPO listing on EMERGE platform with standard surveillance measures